Biotricity INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
BTCY
Biotricity INCIonic Ventures LLC and affiliated entities have updated their Schedule 13G filing to report beneficial ownership of 3,096,987 shares of BioTricity Inc. common stock, representing 9.9% of the outstanding shares.
OQB
BTCY
Biotricity INCIonic Ventures and its affiliates updated their beneficial ownership in Biotricity Inc. to 9.99% of common stock, including convertible preferred shares.
OQB
BTCY
Biotricity INCIonic Ventures and its affiliates disclose a 9.9% beneficial ownership stake in Biotricity Inc., totaling 2,839,930 shares, including common and convertible preferred stock.
OQB
BTCY
Biotricity INCSCHEDULE 13G/A: Ionic Ventures Group Maintains 9.9% Stake in Biotricity Inc., Details Preferred Stock Conversion Limitations
Ionic Ventures, LLC and its affiliated reporting persons have filed an Amendment No. 3 to their Schedule 13G, reaffirming their beneficial ownership of 9.9% of Biotricity Inc.'s common stock, subject to a 9.99% beneficial ownership limitation on preferred stock conversions.
OQB
BTCY
Biotricity INCSCHEDULE 13G/A: Ionic Ventures Updates Stake in Biotricity Inc., Maintains 9.9% Beneficial Ownership
Ionic Ventures, LLC and its affiliates have filed an amended Schedule 13G, updating their beneficial ownership in Biotricity Inc. to 9.9% of the common stock, reflecting holdings of common stock and convertible preferred stock subject to a 9.99% ownership limitation.